Original Research
Published on 19 Apr 2021
Tyrosine Kinase Inhibitor Cabozantinib Inhibits Murine Renal Cancer by Activating Innate and Adaptive Immunity
in Pharmacology of Anti-Cancer Drugs
- 5,064 views
- 10 citations
Original Research
Published on 19 Apr 2021
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 16 Apr 2021
in Pharmacology of Anti-Cancer Drugs
Systematic Review
Published on 16 Apr 2021
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 13 Apr 2021
in Pharmacology of Anti-Cancer Drugs
Review
Published on 12 Apr 2021
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 06 Apr 2021
in Pharmacology of Anti-Cancer Drugs
Case Report
Published on 01 Apr 2021
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 01 Apr 2021
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 01 Apr 2021
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 30 Mar 2021
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 29 Mar 2021
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 26 Mar 2021
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 26 Mar 2021
in Pharmacology of Anti-Cancer Drugs
Review
Published on 26 Mar 2021
in Pharmacology of Anti-Cancer Drugs
Review
Published on 26 Mar 2021
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 25 Mar 2021
in Pharmacology of Anti-Cancer Drugs